In-vitro Lung Model Market
In-vitro Lung Model Market - Global Industry Assessment & Forecast
#
Pages:
120
Base Year:
2022
Mar - 2023
Format:
Report Code:
VMR-1337
Segments Covered
By
Type 2D Cell Models, 3D Cell Models
-
By
Application Drug Screening, Toxicology, Others
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 321.20 Million |
 Revenue 2030:
|
USD 1112.58 Million |
 Revenue CAGR
(2023 - 2030): |
16.80% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
In-vitro Lung Model Market Segment Analysis
- In-vitro Lung Model Type Outlook (Revenue, USD Million, 2018 - 2030)
- 2D Cell Models
- 3D Cell Models
- In-vitro Lung Model Application Outlook (Revenue, USD Million, 2018 - 2030)
- Drug Screening
- Toxicology
- Others
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America In-vitro Lung Model Market, by Type
- 2D Cell Models
- 3D Cell Models
-
North America In-vitro Lung Model Market, by Application
- Drug Screening
- Toxicology
- Others
- U.S.
- U.S. In-vitro Lung Model Market, by Type
- 2D Cell Models
- 3D Cell Models
- U.S. In-vitro Lung Model Market, by Application
- Drug Screening
- Toxicology
- Others
- U.S. In-vitro Lung Model Market, by Type
- Canada
- Canada In-vitro Lung Model Market, by Type
- 2D Cell Models
- 3D Cell Models
- Canada In-vitro Lung Model Market, by Application
- Drug Screening
- Toxicology
- Others
- Canada In-vitro Lung Model Market, by Type
-
Mexico
- Mexico In-vitro Lung Model Market, by Type
- 2D Cell Models
- 3D Cell Models
- Mexico In-vitro Lung Model Market, by Application
- Drug Screening
- Toxicology
- Others
- Mexico In-vitro Lung Model Market, by Type
-
North America In-vitro Lung Model Market, by Type
- Europe
-
Europe In-vitro Lung Model Market, by Type
- 2D Cell Models
- 3D Cell Models
-
Europe In-vitro Lung Model Market, by Application
- Drug Screening
- Toxicology
- Others
- U. K.
- U.K. In-vitro Lung Model Market, by Type
- 2D Cell Models
- 3D Cell Models
- U.K. In-vitro Lung Model Market, by Application
- Drug Screening
- Toxicology
- Others
- U.K. In-vitro Lung Model Market, by Type
- France
- France In-vitro Lung Model Market, by Type
- 2D Cell Models
- 3D Cell Models
- France In-vitro Lung Model Market, by Application
- Drug Screening
- Toxicology
- Others
- France In-vitro Lung Model Market, by Type
-
Germany
- Germany In-vitro Lung Model Market, by Type
- 2D Cell Models
- 3D Cell Models
- Germany In-vitro Lung Model Market, by Application
- Drug Screening
- Toxicology
- Others
- Germany In-vitro Lung Model Market, by Type
-
Italy
- Italy In-vitro Lung Model Market, by Type
- 2D Cell Models
- 3D Cell Models
- Italy In-vitro Lung Model Market, by Application
- Drug Screening
- Toxicology
- Others
- Italy In-vitro Lung Model Market, by Type
-
Spain
- Spain In-vitro Lung Model Market, by Type
- 2D Cell Models
- 3D Cell Models
- Spain In-vitro Lung Model Market, by Application
- Drug Screening
- Toxicology
- Others
- Spain In-vitro Lung Model Market, by Type
-
Rest of Europe
- Rest of Europe In-vitro Lung Model Market, by Type
- 2D Cell Models
- 3D Cell Models
- Rest of Europe In-vitro Lung Model Market, by Application
- Drug Screening
- Toxicology
- Others
- Rest of Europe In-vitro Lung Model Market, by Type
-
Europe In-vitro Lung Model Market, by Type
- Asia Pacific
-
Asia Pacific In-vitro Lung Model Market, by Type
- 2D Cell Models
- 3D Cell Models
-
Asia Pacific In-vitro Lung Model Market, by Application
- Drug Screening
- Toxicology
- Others
- China
- China In-vitro Lung Model Market, by Type
- 2D Cell Models
- 3D Cell Models
- China In-vitro Lung Model Market, by Application
- Drug Screening
- Toxicology
- Others
- China In-vitro Lung Model Market, by Type
- Japan
- Japan In-vitro Lung Model Market, by Type
- 2D Cell Models
- 3D Cell Models
- Japan In-vitro Lung Model Market, by Application
- Drug Screening
- Toxicology
- Others
- Japan In-vitro Lung Model Market, by Type
-
Germany
- Germany In-vitro Lung Model Market, by Type
- 2D Cell Models
- 3D Cell Models
- Germany In-vitro Lung Model Market, by Application
- Drug Screening
- Toxicology
- Others
- Germany In-vitro Lung Model Market, by Type
-
India
- India In-vitro Lung Model Market, by Type
- 2D Cell Models
- 3D Cell Models
- India In-vitro Lung Model Market, by Application
- Drug Screening
- Toxicology
- Others
- India In-vitro Lung Model Market, by Type
-
South Korea
- South Korea In-vitro Lung Model Market, by Type
- 2D Cell Models
- 3D Cell Models
- South Korea In-vitro Lung Model Market, by Application
- Drug Screening
- Toxicology
- Others
- South Korea In-vitro Lung Model Market, by Type
-
South East Asia
- South East Asia In-vitro Lung Model Market, by Type
- 2D Cell Models
- 3D Cell Models
- South East Asia In-vitro Lung Model Market, by Application
- Drug Screening
- Toxicology
- Others
- South East Asia In-vitro Lung Model Market, by Type
-
Rest of Asia Pacific
- Rest of Asia Pacific In-vitro Lung Model Market, by Type
- 2D Cell Models
- 3D Cell Models
- Rest of Asia Pacific In-vitro Lung Model Market, by Application
- Drug Screening
- Toxicology
- Others
- Rest of Asia Pacific In-vitro Lung Model Market, by Type
-
Asia Pacific In-vitro Lung Model Market, by Type
- Latin America
-
Latin America In-vitro Lung Model Market, by Type
- 2D Cell Models
- 3D Cell Models
-
Latin America In-vitro Lung Model Market, by Application
- Drug Screening
- Toxicology
- Others
- Brazil
- Brazil In-vitro Lung Model Market, by Type
- 2D Cell Models
- 3D Cell Models
- Brazil In-vitro Lung Model Market, by Application
- Drug Screening
- Toxicology
- Others
- Brazil In-vitro Lung Model Market, by Type
- Argentina
- Argentina In-vitro Lung Model Market, by Type
- 2D Cell Models
- 3D Cell Models
- Argentina In-vitro Lung Model Market, by Application
- Drug Screening
- Toxicology
- Others
- Argentina In-vitro Lung Model Market, by Type
-
Rest of Latin America
- Rest of Latin America In-vitro Lung Model Market, by Type
- 2D Cell Models
- 3D Cell Models
- Rest of Latin America In-vitro Lung Model Market, by Application
- Drug Screening
- Toxicology
- Others
- Rest of Latin America In-vitro Lung Model Market, by Type
-
Latin America In-vitro Lung Model Market, by Type
- Middle East & Africa
-
Middle East & Africa In-vitro Lung Model Market, by Type
- 2D Cell Models
- 3D Cell Models
-
Middle East & Africa In-vitro Lung Model Market, by Application
- Drug Screening
- Toxicology
- Others
- GCC Countries
- GCC Countries In-vitro Lung Model Market, by Type
- 2D Cell Models
- 3D Cell Models
- GCC Countries In-vitro Lung Model Market, by Application
- Drug Screening
- Toxicology
- Others
- GCC Countries In-vitro Lung Model Market, by Type
- South Africa
- South Africa In-vitro Lung Model Market, by Type
- 2D Cell Models
- 3D Cell Models
- South Africa In-vitro Lung Model Market, by Application
- Drug Screening
- Toxicology
- Others
- South Africa In-vitro Lung Model Market, by Type
-
Rest of Middle East & Africa
- Rest of Middle East & Africa In-vitro Lung Model Market, by Type
- 2D Cell Models
- 3D Cell Models
- Rest of Middle East & Africa In-vitro Lung Model Market, by Application
- Drug Screening
- Toxicology
- Others
- Rest of Middle East & Africa In-vitro Lung Model Market, by Type
-
Middle East & Africa In-vitro Lung Model Market, by Type
- North America
Vantage Market
Research | 21-Feb-2022
FAQ
Frequently Asked Question
What is the global demand for In-vitro Lung Model in terms of revenue?
-
The global In-vitro Lung Model valued at USD 321.20 Million in 2022 and is expected to reach USD 1112.58 Million in 2030 growing at a CAGR of 16.80%.
Which are the prominent players in the market?
-
The prominent players in the market are Epithelix (Switzerland), MatTek Corporation (US), Lonza (Switzerland), ATCC (US), InSphero (Switzerland), Emulate (US), AlveoliX (Switzerland), Oncotheis (Switzerland), Insphero (Switzerland), TissUse (Switzerland), Mimetas (Netherlands), and CN Bio Innovations (UK)..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 16.80% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the In-vitro Lung Model include
- Rising Prevalence of Lung Diseases and Increasing Research on Lung Disorders
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the In-vitro Lung Model in 2022.
